. July 25, 2012 - Val Brickates Kennedy Tuesday’s biggest

New Post Public Reply Private Reply Replies (0) Message Board

Nov 22, 2013 at 6:10 PM

. July 25, 2012 - Val Brickates Kennedy
Tuesday’s biggest gainers and decliners 6:42 p.m. March 1, 2011 - Kate Gibson
Novavax grabs drug-stock spotlight 12:49 p.m. March 1, 2011 - Val Brickates Kennedy
Novavax shares rally on government contract 10:03 a.m. March 1, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 3:38 p.m. July 27, 2010 - MarketWatch
Baxter, Affymetrix lead drug stocks lower 1:05 p.m. April 22, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:56 p.m. March 24, 2010 - MarketWatch
Poniard, Genzyme lead drug stocks south 10:10 a.m. March 24, 2010 - Val Brickates Kennedy
Drug stocks turn higher; Shire, XenoPort gain 12:59 p.m. Feb. 19, 2010 - Val Brickates Kennedy
Monday's biggest gaining and declining stocks 5:16 p.m. Feb. 8, 2010 - MarketWatch
Drug stocks turn higher; Cell Therapeutics tumbles 1:14 p.m. Feb. 8, 2010 - Val Brickates Kennedy
Novavax shares down 9% 9:37 a.m. Feb. 8, 2010 - Nick Godt
Novavax, Rovi end flu-vaccine-development plan 2:27 a.m. Feb. 8, 2010 - Robert Daniel
Novavax raises $21 million in stock offering 9:10 a.m. Dec. 9, 2009 - Val Brickates Kennedy
Dyax, Santarus, CytRx soar; Hemispherx craters 11:38 a.m. Dec. 2, 2009 - Val Brickates Kennedy
Drug stocks split; Theravance slides on setback 1:22 p.m. Nov. 30, 2009 - Val Brickates Kennedy
Novavax sees Phase III vaccine testing in 2010 9:32 a.m. Nov. 30, 2009 - Val Brickates Kennedy
Inovio, Merck gain; Novavax falls 4:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 4:25 p.m. Nov. 20, 2009 - MarketWatch

New Top Stocks to Buy Under $10 with Big Upside 7:16 a.m. Nov. 18, 2013 - 247WallSt.com
Breakthrough In Virus Vaccination Can Instigate A Super Run Of Novavax 12:41 p.m. Nov. 17, 2013 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:11 a.m. Nov. 14, 2013 - benzinga.com
Novavax Shares Edge Higher as the New England Journal of Medicine Has Published Data on Co.'s Bird Flu Vaccine 4:26 p.m. Nov. 13, 2013 - benzinga.com
Novavax Management Discusses Q3 2013 Results - Earnings Call Transcript 7:20 p.m. Nov. 7, 2013 - Seeking Alpha
Two Speculative Biotech Stocks 11:00 a.m. Oct. 31, 2013 - RealMoney.com
Buy Novavax On Vaccine Market Growth 2:31 p.m. Oct. 30, 2013 - Seeking Alpha
First Week Of NVAX December 21st Options Trading 10:54 a.m. Oct. 23, 2013 - TheStreet.com
Wall Street Analysts’ Top Stocks to Buy Trading Under $10 7:35 a.m. Sept. 30, 2013 - 247WallSt.com
John McCamant Scans Under The Radar For Promising Biotechs 9:11 a.m. Sept. 27, 2013 - Seeking Alpha
NVAX: Insiders Vs. Shorts 2:48 p.m. Sept. 26, 2013 - TheStreet.com
First Week Of November 16th Options Trading For Novavax (NVAX) 2:05 p.m. Sept. 26, 2013 - TheStreet.com
Novavax: A Vaccine Company On The Rise 2:31 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax: Why Investors Are Excited Now 12:22 p.m. Sept. 25, 2013 - Seeking Alpha
Novavax, Inc. - Shareholder/Analyst Call 4:10 p.m. Sept. 24, 2013 - Seeking Alpha
Novavax's CEO Hosts Analyst and Investor Update Conference (Transcript) 4:10 p.m. Sept. 24, 2013 - Seeking Alpha
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 7:03 a.m. Sept. 24, 2013 - benzinga.com
Novavax Prices Public Offering of Common Stock at $3.14 per Share 7:02 a.m. Sept. 24, 2013 - benzinga.com
3 Stocks Under $5 With Triple-Digit Upside 4:04 p.m. Sept. 20, 2013 - Seeking Alpha
3 Stocks Under $5 With Huge Upside 8:30 a.m. Sept. 20, 2013 - streetauthority.com

Financial Reports, Partnerships, Settlement Agreements, and Strategic Acquisitions - Research Report on Mallinckrodt, WellCare, Mindray, Oxygen Biotherapeutics, and Novavax 8:00 a.m. Nov. 19, 2013 - PR Newswire
New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax' Vaccine Against H7N9 Avian Flu 5:01 p.m. Nov. 13, 2013 - GlobeNewswire
Novavax Reports Third-Quarter 2013 Financial Results 4:10 p.m. Nov. 7, 2013 - GlobeNewswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:28 a.m. Nov. 7, 2013 - ACCESSWIRE
Clinical Trials Results, Financial Results, and Upcoming Earnings Releases- Research Report on Teleflex, Oxygen Biotherapeutics, Novavax, Prana Biotechnology and Hanger Orthopedic 8:00 a.m. Nov. 4, 2013 - PR Newswire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013 4:58 p.m. Oct. 30, 2013 - GlobeNewswire
Pre-Market Review: MannKind Corp., Galena Biopharma Inc., Ariad Pharmaceuticals Inc., and Novavax Inc. 3:40 p.m. Oct. 10, 2013 - PR Newswire
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray 8:00 a.m. Oct. 9, 2013 - PR Newswire
Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate 4:35 p.m. Oct. 7, 2013 - GlobeNewswire
Novavax Completes $100 Million Public Offering of Common Stock 11:29 a.m. Sept. 27, 2013 - GlobeNewswire
Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst 8:00 a.m. Sept. 27, 2013 - PR Newswire
Novavax Prices Public Offering of Common Stock 8:06 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA 8:00 a.m. Sept. 24, 2013 - GlobeNewswire
Novavax to Host an Analyst and Investor Update Call With Webcast 6:25 p.m. Sept. 17, 2013 - GlobeNewswire
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Novavax Highlights Positive Results From Partner's Clinical Trial of Vaccine Using Matrix-M(TM) 9:03 a.m. Sept. 13, 2013 - GlobeNewswire
Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013 5:00 p.m. Sept. 12, 2013 - PR Newswire
ICAAC Presentations Highlight Potential Protective Effects of Novavax' RSV Vaccine Candidate 8:30 a.m. Sept. 11, 2013 - GlobeNewswire
Technical Scrutiny: Novavax Inc., MannKind Corp., Galena Biopharma Inc., and Ariad Pharma Inc. 2:00 p.m. Sept. 10, 2013 - PR Newswire

$NVAX Company News

Novavax Inc. up 16% in premarket 6:52 a.m. Oct. 25, 2012 - Steve Gelsi
Novavax gains 11% on flu vaccine update 11:29 a.m

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

PureHealth's Acid Reflux Solutions: An Investor's Insight

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

SMPL Faces Legal Drama: What Investors Need to Know

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Pizza: The Unlikely Symbol of Universal Togetherness

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...